Side effects of chemotherapy in dermatology.
D000995:Antitubercular Agents / Q000009:adverse effects; D001151:Arsenic / Q000009:adverse effects; D003374:Coumarins / Q000009:adverse effects; D003877:Dermatitis, Contact / Q000209:etiology / Q000276:immunology; D003879:Dermatologic Agents / Q000009:adverse effects*; D004342:Drug Hypersensitivity; D005076:Exanthema / Q000139:chemically induced / Q000473:pathology; D005260:Female; D006046:Gold / Q000009:adverse effects; D006219:Halogens / Q000009:adverse effects; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D006827:Hydantoins / Q000009:adverse effects; D008177:Lupus Vulgaris / Q000139:chemically induced; D008297:Male; D011537:Pruritus / Q000139:chemically induced; D011955:Receptors, Drug; D012834:Silver / Q000009:adverse effects; D012871:Skin Diseases / Q000139:chemically induced; D013449:Sulfonamides / Q000009:adverse effects; D014780:Viruses / Q000187:drug effects
D000995:Antitubercular Agents; D003374:Coumarins; D003879:Dermatologic Agents; D006219:Halogens; D006827:Hydantoins; D011955:Receptors, Drug; D013449:Sulfonamides; D012834:Silver; D006046:Gold; D001151:Arsenic